Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health Outcomes
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Hospital Benin, Congo, The Democratic Republic
Closing the Knowledge Gap in anti-TNF Cycling in Rheumatoid Arthritis
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Increasing Healthcare Professional Skills For COVID-19 Vaccine Discussions That Advocate Vaccination
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Management of Adults and Adolescents with Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Sickle Cell Disease Transition in Care
Release Date:
Partner: National Alliance of Sickle Cell Centers
Review Process: Expert Review Panel
Quality Improvement Rare Disease USA
2025 Rheumatology Fellowship – United States
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA
Closing the Knowledge Gap in the Diagnosis and Management of Idiopathic Inflammatory Myopathies (IIM)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Invasive Mold Diseases (IMD) & Treatment Outcomes
Release Date:
Review Process: Pfizer Internal
Research Hospital Australia, Austria, Belgium, China, France, Germany, Greece, Italy, Korea, Netherlands, Spain, Switzerland, United Kingdom
Implementing Updated RSV Immunization Recommendations for Older Adults
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Optimization of Health IT to support RSV Immunizations
Release Date:
Review Process: Expert Review Panel
Quality Improvement Vaccines USA
Title
Grant Type
Focus Area
Country
Application Due Date
Cardiac Transthyretin Amyloid (ATTR) Fellowship
Release Date:
Partner: International Society of Amyloidosis
Review Process: Expert Review Panel
Fellowship Rare Disease All
Clinical Diagnosis and Management of Endometriosis
Release Date:
Partner: Myovant Sciences
Review Process: Pfizer Internal
Education Internal Medicine USA
Management of Uterine Fibroids
Release Date:
Partner: Myovant Sciences
Review Process: Pfizer Internal
Education Internal Medicine USA
Rapid Education on Drug-Drug Interactions in COVID-19 Outpatient Treatment
Release Date:
Review Process: Pfizer Internal
Education Hospital USA
2023 Global Migraine ASPIRE
Release Date:
Review Process: Expert Review Panel
Research Internal Medicine All
Promoting Pain Treatment in Musculoskeletal Pain
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Japan
Improve the Treatment Environment for Cancer Pain Patients
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Japan
LMIC Pharmacovigilance Education
Release Date:
Review Process: Pfizer Internal
Education Patient Safety Kenya, Lesotho, Swaziland
Knowledge Gaps in Managing Obesity and COVID-19
Release Date:
Review Process: Pfizer Internal
Education Hospital USA
Immunotherapy in Urothelial Carcinoma (USA, Europe, Asia, Latin America, Canada, and Global)
Release Date:
Partner: Merck KGaA, Darmstadt, Germany, EMD Serono
Review Process: Pfizer Internal
Education Oncology All
Promoting timely diagnosis of ATTR-CM in China Competitive Grant Program - internal Pfizer review process
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease China
Quality Improvement Initiatives to Address Healthcare Barriers for Cardiac Amyloidosis
Release Date:
Partner: National Medical Association
Review Process: Expert Review Panel
Quality Improvement Rare Disease USA